You are logged on as Guest.
RegisterLoginShopping cart (Empty)
 United States

GLP and Exendin

Browse our Product Range

GLP Antibodies
Exendin Antibodies
GLP Proteins
New GLP and Exendin Products

Glucagon precursor schematic (GRPP = glicentin-related pancreatic polypeptide; IP = intermediate peptide)

GLP (glucagon-like peptide) functions in the regulation of blood glucose through insulin, and plays a role in obesity and diabetes. GLP-1 is an important gastrointestinal peptide hormone or incretin, which is released when we eat, produced by tissue specific post-translational processing from a glucagon precursor, and inactivated by dipeptidylpeptidase DPP-4 enzymes. In response to eating, increased levels of GLP-1 stimulate insulin secretion and inhibit glucagon release leading to lower blood glucose levels.

Glia Monster

Exendin-4 is a 39 amino-acid peptide found in venom from the Gila monster. It is a member of the glucagon-secretin family of peptide hormones and neuropeptides. As an agonist of the GLP-1 receptor, Exendin-4 is a potent stimulator of insulin secretion and has a much longer half life than GLP-1 (~2 minutes) making it a suitable drug candidate for the treatment of obesity and type-2 diabetes. Administrating GLP-1, GLP-1 analogues like Exendin-4, or DPP-4 inhibitors (drugs) raises insulin levels and prolongs the GLP-1 action of lowering blood glucose in patients with type-2 diabetes and obesity.

Schematic representations of GLP-1 indicating the active, extended and metabolite forms along with select GLP-1 monoclonal antibodies that Enzo Life Sciences offers.
 
©2010 Enzo Life Sciences, Inc.,